| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |